Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8585.18%
operating margin TTM
-9534.48%
revenue TTM
6.26 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -7.91 |
| peg ratio | 0.85 |
| price to book ratio | 3.71 |
| price to sales ratio | 755.73 |
| enterprise value multiple | -8.27 |
| price fair value | 3.71 |
profitability ratios | |
|---|---|
| gross profit margin | 108.47% |
| operating profit margin | -9534.48% |
| pretax profit margin | -8581.86% |
| net profit margin | -8585.18% |
| return on assets | -40.98% |
| return on equity | -41.46% |
| return on capital employed | -49.2% |
liquidity ratios | |
|---|---|
| current ratio | 12.32 |
| quick ratio | 12.30 |
| cash ratio | 1.19 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | -1,607.91 |
| operating cycle | -1,568.04 |
| days of payables outstanding | -17,980.42 |
| cash conversion cycle | 16,412.38 |
| receivables turnover | 9.16 |
| payables turnover | -0.02 |
| inventory turnover | -0.23 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.05 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -7.79 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.08 |
| cash per share | 10.93 |
| operating cash flow per share | -4.02 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -7.79 |
| short term coverage ratios | -58.24 |
| capital expenditure coverage ratio | -65.59 |
Frequently Asked Questions
When was the last time Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) reported earnings?
Crinetics Pharmaceuticals, Inc. (CRNX) published its most recent earnings results on 06-11-2025.
What is Crinetics Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)'s trailing twelve months ROE is -41.46%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Crinetics Pharmaceuticals, Inc. (CRNX) currently has a ROA of -40.98%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CRNX's net profit margin stand at?
CRNX reported a profit margin of -8585.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CRNX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 12.32 in the most recent quarter. The quick ratio stood at 12.30, with a Debt/Eq ratio of 0.05.